Stay updated with breaking news from Infensa Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
China’s vaccine developer MaxHealth Biotechnology raised the biggest private biotech investment in the Asia-Pacific region in July 2022, followed by China Immunotech and Ruibo Bio.
The Quadrant Growth Fund made a major investment in Modibodi in 2019.
Aussie start-up using spider venom to treat heart attacks-
:A team of drug researchers from the University of Queensland (UQ) have developed a new heart attack treatment made from deadly spider venom and are now looking to bring the lifesaving treatment to market through a local start-up. The team said on Monday that the drug candidate was one step closer t ..
Queensland researchers will next year start human trials on a drug, containing a molecule from funnel web venom, which could prevent cell damage caused by heart attacks.